Implantable cardioverter defibrillators in children

Expert Review of Cardiovascular Therapy

Volumn 2, Issue 4, 2004, Pages 561-571

  Chun, Terrence U H ^a   Collins, Kathryn K ^b   Dubin, Anne M ^a  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardioverter Defibrillator; Children; Congenital heart defects; Implantable; Sudden cardiac death

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; SODIUM CHANNEL BLOCKING AGENT;

CHILD; CONGENITAL HEART MALFORMATION; DEFIBRILLATOR; DISEASE ASSOCIATION; EQUIPMENT DESIGN; HEART DEVELOPMENT; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE PACING; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONG QT SYNDROME; QUALITY OF LIFE; REVIEW; SUDDEN DEATH; TREATMENT INDICATION; VEIN THROMBOSIS;

ARRHYTHMIA; BODY SIZE; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT DESIGN; HUMANS;

EID: 4043048849     PISSN: 14779072     EISSN: None     Source Type: Journal    
DOI: 10.1586/14779072.2.4.561     Document Type: Review

References (63)

1. Schindler MB, Bohn D, Cox PN et al. outcome of out-of-hospital cardiac or respiratory arrest in children. N. Engl. J. Med. 335 (20), 1473-1479 (1996).
2. Liberthson RF. Sudden death from cardiac causes in children and young adults. N. Engl. J. Med. 334(16), 1039-1044 (1996).
3. Silka MJ, Hardy BG, Menashe VD, Morris CD. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J. Am. Coll. Cardiol. 32(1), 245-251 (1998).
4. Oechslin EN, Harrison DA, Connelly MS, Webb GD, Siu SC. Mode of death in adults with congenital heart disease. Am. J. Cardiol. 86(10), 1111-1116 (2000).
5. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N. Engl. J. Med. 337(22), 1576-1583 (1997).
6. Moss AJ, Zareba W, Hall WJ et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N. Engl. J. Med. 346(12), 877-883 (2002).
7. Bardy GH, Lee KL, Mark DB et al. Sudden Cardiac Death in Heart Failure Trial. Am. Coll. Cardiol. Annual Scientific Sessions. New Orleans, LA, USA, 7th-10th March 2004.
8. Gregoratos G, Abrams J, Epstein AE et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J. Am. Coll. Cardiol. 40(9), 1703-1719 (2002).
9. Chatrath R, Porter CB, Ackerman MJ. Role of transvenous implantable cardioverter defibrillators in preventing sudden cardiac death in children, adolescents and young adults. Mayo. Clin. Proc. 77(3), 226-231 (2002).
10. Stefanelli CB, Bradley DJ, Leroy S et al. Implantable cardioverter defibrillator therapy for life-threatening arrhythmias in young patients. J. Interv. Card. Electrophysiol. 6(3), 235-244 (2002).
11. Wilson WR, Greer GE, Grubb BP. Implantable cardioverter defibrillators in children: a single-institutional experience. Ann. Thorac. Surg. 65(3), 775-778 (1998).
12. Gradaus R, Wollmann C, Kobe J et al. Potential benefit from implantable cardioverter-defibrillator therapy in children and young adolescents. Heart 90(3), 328-329 (2004).
13. Link MS, Hill SL, Cliff DL et al. Comparison of frequency of complications of implantable cardioverter defibrillators in children versus adults. Am. J. Cardiol. 83(2), 263-266, A5-A6 (1999).
14. Silka MJ, Kron J, Dunnigan A, Dick M 2nd. Sudden cardiac death and the use of implantable cardioverter defibrillators in pediatric patients. The Pediatric Electrophysiology Society. Circulation 87(3), 800-807 (1993).
15. Dore A, Santagata P, Dubuc M, Mercier LA. Implantable cardioverter defibrillators in adults with congenital heart disease: a single center experience. Pacing Clin. Electrophysiol, 27(1), 47-51 (2004).
16. Maron BJ. Risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Cardiol. Rev. 10(3), 173-181 (2002).
17. Maron BJ. Hypertrophic cardiomyopathy. Lancet 350(9071), 127-133 (1997).
18. Roberts R, Sigwart U. New concepts in hypertrophic cardiomyopathies, part I. Circulation 104(17), 2113-2116 (2001).
19. Monserrat L, Elliott PM, Girrieno JR et al. Nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. J. Am Coll. Cardiol. 42(5), 873-879 (2003).
20. Maron BJ, Shen WK, Link MS et al. Efficacy of implantable cardioverter defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N. Engl. J. Med. 342(6), 365-373 (2000).
21. Begley DA, Mohiddin SA, Tripodi D, Winkler JB, Fananapazir L. Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy Pacing Clin. Electrophysiol. 26(9), 1887-1896 (2003).
22. Zareba W, Moss AJ, Schwartz PJ et al. Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N. Engl. J. Med. 339(14), 960-965 (1998).
23. Priori SG, Schwartz PJ, Napolitano C et al. Risk stratification in the long-QT syndrome. N. Engl. J. Med. 348(19), 1866-1874 (2003).
24. Moss AJ, Zareba W, Hall WJ et al. Effectiveness and limitations of β-blocker therapy in congenital long-QT syndrome. Circulation 101(6), 616-623 (2000).
25. Zareba W, Moss AJ, Daubert JP et al. Implantable cardioverter defibrillator in high-risk long-QT syndrome patients. J. Cardiovasc. Electrophysiol. 14(4), 337-341 (2003).
26. Nollert GD, Dabritz SH, Schmoeckel M, Vicol C, Reichart B. Risk factors for sudden death after repair of tetralogy of Fallot. Ann. Thorac. Surg. 76(6), 1901-1905 (2003).
27. Alexander ME, Walsh EP, Saul JP, Epstein MR, Triedman JK Value of programmed ventricular stimulation in patients with. congenital heart disease. J. Cardiovasc. Electrophysiol. 10(8), 1033-1044 (1999).
28. Morrow WR, Frazier E, Naftel DC. Survival after listing for cardiac transplantation in children. 11(2), 99-105 (2000).
29. Dubin AM, Berul CI, Bevilacqua LM et al. The use of implantable cardioverter defibrillators in pediatric patients awaiting heart transplantation. J. Card. Fail. 9(5), 375-379 (2003).
30. Kistler PM, Fynn SP, Mond HG. The subpectoral pacemaker implant. Pacing Clin. Electrophysiol 27(3), 361-364 (2004).
31. Lee JC, Shannon K, Boyle NG, Klitzner TS, Bersohn MM. Evaluation of safety and efficacy of pacemaker and defibrillator implantation by axillary incision in pediatric patients. Pacing Clin. Electrophysiol 27(3), 304-307 (2004).
32. Gold MR, Peters RW, Johnson JW, Shorofsky SR. Complications associated with pectoral cardioverter-defibrillator implantation: comparison of subcutaneous and submuscular approaches. Worldwide Jewel Investigators. J. Am. Coll. Cardiol. 28(5), 1278-1282 (1996).
33. Trappe HJ. The 'modern' implantable cardioverter-defibrillator: comparing it to those of the late 1980s. Am. J. Cardiol. 78(5A), 3-8 (1996).
34. Kennergren C. Impact of implant techniques on complications with current implantable cardioverter defibrillator systems. Am. J. Cardiol. 78(5A), 15-20 (1996).
35. Calkins H, Ramza BM, Brinker J et al. Prospective randomized comparison of the safety and effectiveness of Placement of endocardial Pacemaker and defibrillator leads using the extrathoracic subclavian vein guided by contrast venography versus the cephalic approach. Pacing Clin. Electrophysiol. 24(4 Pt 1), 456-464 (2001).
36. Tse HF, Lau CP, Leung SK. A cephalic vein cutdown and venography technique to facilitate pacemaker and defibrillator lead implantation. Pacing Clin. Electrophysiol. 24(4 Pt 1), 469-473 (2001).
37. Pavia S, Wilkoff B. The management of surgical complications of pacemaker and implantable cardioverter defibrillators. Curr. Opin. Cardiol. 16(1), 66-71 (2001).
38. Cooper JM, Stephenson EA, Berul CI, Walsh EP, Epstein LM. Implantable cardioverter defibrillator lead complications and laser extraction in children and young adults with congenital heart disease: implications for implantation and management. J. Cardiovasc. Electrophysiol. 14(4), 344-349 (2003).
39. Rinaldi CA, Simon RD, Geelen P et al. A randomized prospective study of single-coil versus dual-coil defibrillation in patients with ventricular arrhythmias undergoing implantable cardioverter defibrillator therapy. Pacing Clin. Electrophysiol. 26(8), 1684-1690 (2003).
40. Chevalier P, Moncada E, Canu G et al. Symptomatic pericardial disease associated with patch electrodes of the automatic implantable cardioverter defibrillator: an underestimated complication? Pacing Clin. Electrophysiol. 19(12 Pt 1), 2150-2152 (1996).
41. Gradaus R, Hammel D, Kotthoff S, Bocker D. Nonthoracotomy implantable cardioverter defibrillator placement in children: use of subcutaneous array leads and abdominally placed implantable cardioverter defibrillators in children. J. Cardiovasc. Electrophysiol. 12(3), 356-360 (2001).
42. Berul CI, Triedman JK, Forbess J et al. Minimally invasive cardioverter defibrillator implantation for children: an animal model and pediatric case report. Pacing Clin. Electrophysiol. 24(12), 1789-1794 (2001).
43. Luedemann M, Hund K, Stertmann W et al. Implantable cardioverter defibrillator in a child using a single subcutaneous array lead and an abdominal active can. Pacing Clin. Electrophysiol. 27(1), 117-119 (2004).
44. Madan N, Gaynor JW, Tanel R et al. Single-finger subcutaneous defibrillation lead and 'active can': a novel minimally invasive defibrillation configuration for implantable cardioverter defibrillator implantation in a young child. J. Thorac. Cardiovasc. Surg. 126(5), 1657-1659 (2003).
45. Watanabe H, Hayashi J, Haga M et al. Successful implantation of a cardioverter defibrillator in an infant. Ann. Thorac. Surg. 72(6), 2125-2127 (2001).
46. Greene AE, Berger JT, Heshmat Y, Kuehl KS. Transcutaneous implantation of an internal cardioverter defibrillator in a small infant with recurrent myocardial ischemia and cardiac arrest simulating sudden infant death syndrome. Pacing Clin. Electrophysiol. 27(1), 112-116 (2004).
47. Alexander ME, Cecchin F, Walsh EP et al. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J. Cardiovasc. Electrophysiol. 15(1), 72-76 (2004).
48. Rinaldi CA, Simon RD, Baszko A et al. A 17 year experience of inappropriate shock therapy in patients with implantable cardioverter defibrillators: are we getting any better? Heart 90(3), 330-331 (2004).
49. Wilkoff BL, Kuhlkamp V, Volosin K et al. Critical analysis of dual-chamber implantable cardioverter-defibrillator arrhythmia detection: results and technical considerations. Circulation 103(3), 381-386 (2001).
50. Love BA, Barrett KS, Alexander ME et al. Supraventricular arrhythmias in children and young adults with implantable cardioverter defibrillators. J. Cardiovasc. Electrophysiol. 12(10), 1097-1101 (2001).
51. Lickfett L, Bitzen A, Arepally A et al. Incidence of venous obstruction following insertion of an implantable cardioverter defibrillator. A study of systematic contrast venography on patients presenting for their first elective ICD generator replacement. Europace 6(1), 25-31 (2004).
52. Sticherling C, Chough SP, Baker RL et al. Prevalence of central venous occlusion in patients with chronic defibrillator leads. Am. Heart J. 141(5), 813-816 (2001).
53. Friedman RA, Van Zandt H, Collins E, LeGras M, Perry J. Lead extraction in young patients with and without congenital heart disease using the subclavian approach. Pacing Clin. Electrophysiol. 19(5), 778-783 (1996).
54. Saad EB, Saliba WI, Schweikert RA et al. Nonthoracotomy implantable defibrillator lead extraction: results and comparison with extraction of pacemaker leads. Pacing Clin. Electrophysiol. 26(10), 1944-1950 (2003).
55. Epstein LM, Byrd CL, Wilkoff BL et al. Initial experience with larger laser sheaths for the removal of transvenous pacemaker and implantable defibrillator leads. Circulation 100(5), 516-525 (1999).
56. Bracke F, Meijer A, Van Gelder B. Extraction of pacemaker and implantable cardioverter defibrillator leads: patient and lead characteristics in relation to the requirement of extraction tools. Pacing Clin. Electrophysiol. 25(7), 1037-1040 (2002).
57. Stojanov P, Veliminovic D, Hrnjak V et al. Absorbable suture technique: solution to the growth problem in pediatric pacing with endocardial leads. Pacing Clin. Electrophysiol. 21 (1 Pt 1), 65-68 (1998).
58. Gasparini M, Mantica M, Galimberti P et al. Inferior vena cava loop of the implantable cardioverter defibrillator endocardial lead: a possible solution of the growth problem in pediatric implantation. Pacing Clin. Electrophysiol. 23(12), 2108-2012 (2000).
59. Antretter H, Hangler H, Colvin J, Laufer G. Inferior vena caval loop of an endocardial pacing lead did not solve the growth problem in a child. Pacing Clin. Electrophysiol. 24(11), 1706-1708; Discussion 1709 (2001).
60. Dubin AM, Batsford WP, Lewis RJ, Rosenfeld LE. Quality-of-life in patients receiving implantable cardioverter defibrillators at or before age 40. Pacing Clin. Electrophysiol. 19(11 Pt 1), 1555-1559 (1996).
61. DeMaso DR, Lauretti A, Spieth L et al. Psychosocial factors and quality of life in children and adolescents with implantable cardioverter defibrillators. Am. J. Cardiol. 93(5), 582-587 (2004).
62. Sears SF, Conti JB. Implantable cardioverter defibrillators for children and young adolescents: mortality benefit confirmed - what's next? Heart 90(3), 241-242 (2004).
63. Sears SF Jr, Burns JL, Handberg E, Sotile WM, Conti JB. Young at heart: understanding the unique psychosocial adjustment of young implantable cardioverter defibrillator recipients. Pacing Clin. Electrophysiol. 24(7), 1113-1117 (2001).